A new mechanism for blocking myeloid-derived suppressor cells by CpG

Clinical Cancer Research

Volumn 17, Issue 7, 2011, Pages 1645-1648

  Lechner, Melissa G ^a   Epstein, Alan L ^b  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; AMILORIDE; ANTINEOPLASTIC AGENT; CELECOXIB; CPG OLIGODEOXYNUCLEOTIDE; DENDRITIC CELL VACCINE; DOCETAXEL; FLUOROURACIL; GEMCITABINE; GW 2580; RETINOIC ACID; SILDENAFIL; SUNITINIB; UNCLASSIFIED DRUG;

ANTIBODY RESPONSE; ANTINEOPLASTIC ACTIVITY; B CELL LYMPHOMA; BREAST CARCINOMA; CANCER IMMUNOTHERAPY; CELLULAR IMMUNITY; COLON CARCINOMA; DRUG CYTOTOXICITY; DRUG MECHANISM; DRUG TARGETING; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; IMMUNOPATHOLOGY; KIDNEY CARCINOMA; LUNG CARCINOMA; LYMPHOCYTE DEPLETION; MELANOMA; MESOTHELIOMA; MYELOID DERIVED SUPPRESSOR CELL; NONHUMAN; NOTE; PRIORITY JOURNAL; PROSTATE CARCINOMA; SIGNAL TRANSDUCTION; SOLID TUMOR; SUPPRESSOR CELL; THYMOMA; TUMOR IMMUNITY;

ANIMALS; ANTINEOPLASTIC AGENTS; DNA; HUMANS; IMMUNE TOLERANCE; IMMUNOTHERAPY; MYELOID CELLS; NEOPLASMS; TOLL-LIKE RECEPTOR 9;

EID: 79953301968     PISSN: 10780432     EISSN: 15573265     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-11-0024     Document Type: Note

References (18)

1. Zoglmeier C, Bauer H, Noerenberg D, Wedekind G, Bittner P, Sandholzer N, et al. CpG blocks immune suppression by myeloid-derived suppressor cells in tumor-bearing mice. Clin Cancer Res 2011;7:1765-75.
2. Sadun RE, Sachsman SM, Chen X, Christenson KW, Morris WZ, Hu P, et al. Immune signatures of murine and human cancers reveal unique mechanisms of tumor escape and new targets for cancer immunotherapy. Clin Cancer Res 2007;13:4016-25. (Pubitemid 47037610)
3. Condamine T, Gabrilovich DI. Molecular mechanisms regulating myeloid-derived suppressor cell differentiation and function. Trends Immunol 2011;32:19-25.
4. Lechner MG, Liebertz DJ, Epstein AL. Characterization of cytokine-induced myeloid-derived suppressor cells from normal human peripheral blood mononuclear cells. J Immunol 2010;185:2273-84.
5. Ko JS, Zea AH, Rini BI, Ireland JL, Elson P, Cohen P, et al. Sunitinib mediates reversal of myeloid-derived suppressor cell accumulation in renal cell carcinoma patients. Clin Cancer Res 2009;15:2148-57.
6. Bose A, Taylor JL, Alber S, Watkins SC, Garcia JA, Rini BI, et al. Sunitinib facilitates the activation and recruitment of therapeutic antitumor immunity in concert with specific vaccination. Int J Cancer 2010. Epub Dec 17.
7. Hartmann G, Weiner GJ, Krieg AM. CpG DNA: a potent signal for growth, activation, and maturation of human dendritic cells. Proc Natl Acad Sci U S A 1999;96:9305-10. (Pubitemid 29374750)
8. Krieg AM. CpG motifs: the active ingredient in bacterial extracts?Nat Med 2003;9:831-5.
9. Paulos CM, Kaiser A, Wrzesinski C, Hinrichs CS, Cassard L, Boni A, et al. Toll-like receptors in tumor immunotherapy. Clin Cancer Res 2007;13:5280-9. (Pubitemid 47510351)
10. Vaknin I, Blinder L, Wang L, Gazit R, Shapira E, Genina O, et al. A common pathway mediated through Toll-like receptors leads to T- and natural killer-cell immunosuppression. Blood 2008;111:1437-47. (Pubitemid 351213431)
11. Nefedova Y, Fishman M, Sherman S, Wang X, Beg AA, Gabrilovich DI. Mechanism of all-trans retinoic acid effect on tumor-associated myeloid-derived suppressor cells. Cancer Res 2007;67:11021-8. (Pubitemid 350145932)
12. Chalmin F, Ladoire S, Mignot G, Vincent J, Bruchard M, Remy-Martin JP, et al. Membrane-associated Hsp72 from tumor-derived exosomes mediates STAT3-dependent immunosuppressive function of mouse and human myeloid-derived suppressor cells. J Clin Invest 2010;120:457-71.
13. Veltman JD, Lambers ME, van Nimwegen M, Hendriks RW, Hoogsteden HC, Aerts JG, et al. COX-2 inhibition improves immunotherapy and is associated with decreased numbers of myeloid-derived suppressor cells in mesothelioma. Celecoxib influences MDSC function. BMC Cancer 2010;10:464.
14. Kodumudi KN, Woan K, Gilvary DL, Sahakian E, Wei S, Djeu JY. A novel chemoimmunomodulating property of docetaxel: suppression of myeloid-derived suppressor cells in tumor bearers. Clin Cancer Res 2010;16:4583-94.
15. Vincent J, Mignot G, Chalmin F, Ladoire S, Bruchard M, Chevriaux A, et al. 5-Fluorouracil selectively kills tumor-associated myeloid-derived suppressor cells resulting in enhanced T cell-dependent antitumor immunity. Cancer Res 2010;70:3052-61.
16. Le HK, Graham L, Cha E, Morales JK, Manjili MH, Bear HD. Gemcitabine directly inhibits myeloid derived suppressor cells in BALB/c mice bearing 4T1 mammary carcinoma and augments expansion of T cells from tumor-bearing mice. Int Immunopharmacol 2009;9:900-9.
17. Priceman SJ, Sung JL, Shaposhnik Z, Burton JB, Torres-Collado AX, Moughon DL, et al. Targeting distinct tumor-infiltrating myeloid cells by inhibiting CSF-1 receptor: combating tumor evasion of antiangiogenic therapy. Blood 2010;115:1461-71.
18. Serafini P, Meckel K, Kelso M, Noonan K, Califano J, Koch W, et al. Phosphodiesterase-5 inhibition augments endogenous antitumor immunity by reducing myeloid-derived suppressor cell function. J Exp Med 2006;203:2691-702. (Pubitemid 44833345)